Projects funded by the NCN
Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of Novel Anticancer Drugs
2021/43/B/NZ7/01611
Keywords:
Enzyme inhibitors Macromolecular structure Drug design Anticancer drugs
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_4: Structural biology
- NZ1_2: Biochemistry
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 2 340 692 PLN
Project start date (Y-m-d): 2022-09-12
Project end date (Y-m-d): 2026-09-11
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.